An exploratory comparative analysis of tyrosine kinase inhibitors or docetaxel in second-line treatment of EGFR wild-type non-small-cell lung cancer: a retrospective real-world practice review at a single tertiary care centre
Ma, K., Cohen, V., Kasymjanova, G., Small, D., Novac, K., Peterson, J., Levitt, A., Agulnik, J.Volume:
22
Language:
english
Journal:
Current Oncology
DOI:
10.3747/co.22.2296
Date:
March, 2015
File:
PDF, 396 KB
english, 2015